Another notable buy includes CRISPR Therapeutics AG (NASDAQ: CRSP ), with ARKK ETF purchasing 31,983 shares, reflecting a continued investment in the gene-editing company with a total dollar value of ...

Palantir shares closed at a record high Wednesday for the second consecutive day, as a cooling of global trade tensions has ...

We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at ...

Palantir is priced like a perfect company, so even solid earnings that only meet expectations can send the stock falling.

Nvidia’s shares soared amid billions of dollars in artificial intelligence investment deals made between US President Donald ...

The Dow opened lower after the Consumer Price Index report showed annual inflation slowed to 2.3%, marking the lowest inflation rate since early 2021. Follow along for live updates on the Dow, S&P 500 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

The trader was considering buying calls that expire on May 30, and he was looking to employ a $110 to $120 call spread ...

While Cisco's valuation never fully recovered, the company's current market cap of $236 billion is still far greater than it ...

In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

PLTR Price Action: Palantir stock is down 14.1% to $106.30 on Tuesday versus a 52-week trading range of $63.40 to $125.41.